Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
24.36
-1.03 (-4.06%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Palvella Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Palvella Therapeutics stock have an average target of 44.43, with a low estimate of 38 and a high estimate of 50. The average target predicts an increase of 82.39% from the current stock price of 24.36.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Palvella Therapeutics stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|
| Strong Buy | 1 | 3 | 5 | 6 |
| Buy | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 3 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +105.25% | Apr 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +55.99% | Apr 1, 2025 |
| Stifel | Stifel | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +84.73% | Mar 26, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +84.73% | Mar 25, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $50 | Buy | Initiates | $50 | +105.25% | Mar 7, 2025 |
Financial Forecast
Revenue This Year
n/a
from 4.51M
Revenue Next Year
n/a
EPS This Year
-5.60
from -7.83
EPS Next Year
-5.36
from -5.60
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | 13.1M |
| Avg | n/a | n/a | 4.5M |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.90 | -1.55 | -2.46 |
| Avg | -5.60 | -5.36 | -5.57 |
| Low | -15.42 | -12.42 | -13.52 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.